| 04.08. | Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022 |  |
| 04.08. | Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022 | |
| 01.08. | Biofrontera's Management, Supervisory Boards Recommend Shareholders Reject Deutsche Bal.. | |
| 01.08. | Biofrontera Receives Australian Patent for Photodynamic Therapy to Treat Skin Diseases | |
| 01.08. | Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted.. | |
| 28.07. | BIOFRONTERA : Announces Exercise of Existing Warrants and Issuance of Warrants in Private .. | |
| 28.07. | BIOFRONTERA INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity.. | |
| 27.07. | Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Pr.. | |
| 27.07. | Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Pr.. | |
| 12.07. | BIOFRONTERA : Announces Preliminary Product Revenues for the Second Quarter of 2022 - Form.. | |
| 12.07. | Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022 | |
| 12.07. | Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022 | |
| 12.07. | Biofrontera Inc. Provides Revenue Guidance for the Second Quarter and Six Months Ended .. | |
| 24.06. | BIOFRONTERA INC.(NASDAQCM : BFRI) dropped from Russell 3000E Value Index | |
| 24.06. | BIOFRONTERA INC.(NASDAQCM : BFRI) dropped from Russell Microcap Value Index | |
| 09.06. | Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing.. | |
| 09.06. | Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing.. | |
| 31.05. | Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conf.. | |
| 31.05. | Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conf.. | |
| 24.05. | BIOFRONTERA INC. : Change in Directors or Principal Officers, Other Events, Financial Stat.. | |
| 24.05. | BIOFRONTERA INC. Change in Directors or Principal Officers (form 8-K/A) | |
| 24.05. | Biofrontera Inc. Appoints Kevin D. Weber to the Nominating and Corporate Governance, Au.. | |
| 24.05. | New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial .. | |
| 23.05. | Biofrontera Inc. announced that it has received $9.40068 million in funding | |
| 20.05. | BIOFRONTERA : Announces Pricing of $9.4 Million Private Placement - Form 8-K | |
| 20.05. | BIOFRONTERA INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity.. | |
| 19.05. | Biofrontera Inc. Announces Closing of $9.4 Million Private Placement | |
| 16.05. | Biofrontera Inc. Announces Pricing of $9.4 Million Private Placement | |
| 16.05. | Biofrontera Inc. Announces Pricing of $9.4 Million Private Placement | |
| 16.05. | Biofrontera Inc. announced that it expects to receive $9.40225 million in funding | |
| 13.05. | Earnings Flash (BFRI) BIOFRONTERA Posts Q1 Revenue $9.8M, vs. Street Est of $9.83M | |
| 13.05. | Biofrontera Inc. Reports First Quarter 2022 Financial Results and Provides a Business U.. | |
| 13.05. | Biofrontera Inc. Reports First Quarter 2022 Financial Results and Provides a Business U.. | |
| 13.05. | Biofrontera Inc. Re-Affirms Earnings Guidance for 2022 | |
| 13.05. | BIOFRONTERA INC. Management's Discussion and Analysis of Financial Condition and Resul.. | |
| 13.05. | Biofrontera Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 | |
| 06.05. | Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022 | |
| 06.05. | Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022 | |
| 05.05. | Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium f.. | |
| 05.05. | Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium f.. | |
| 27.04. | Certain Common Stock of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 2.. | |
| 21.04. | Biofrontera Launches New Patient-Focused Websites for Ameluz® and Xepi® | |
| 14.04. | Biofrontera Shares Retreat 7% After Wednesday's Big Move Higher | |
| 13.04. | Top Midday Gainers | |
| 13.04. | Biofrontera Shares Jump 31% After FDA Approves Contract Laboratory for Ameluz | |
| 13.04. | Biofrontera Says FDA Has Approved German Facility as Contract Laboratory for Testing of.. | |
| 13.04. | Biofrontera Shares Halted After FDA Approves German Lab for Testing Ameluz | |
| 13.04. | Biofrontera Inc. Announces FDA Approval of Biofrontera Pharma GmbH as a Contract Labora.. | |
| 11.04. | Top Premarket Decliners | |
| 11.04. | BIOFRONTERA INC. Management's Discussion and Analysis of Financial Condition and Resul.. | |
| 08.04. | SECTOR UPDATE : Health Care Stocks Enjoy Late Uptick | |
| 08.04. | SECTOR UPDATE : Health Care Stocks Firming in Mostly Higher Market | |
| 08.04. | SECTOR UPDATE : Health Care | |
| 08.04. | European ADRs Move Higher in Friday Trading | |
| 08.04. | Biofrontera Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended De.. | |
| 08.04. | Top Premarket Gainers | |
| 08.04. | Earnings Flash (BFRI) BIOFRONTERA Reports Q4 Revenue $9.2M, vs. Street Est of $9.2M | |
| 08.04. | Biofrontera Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provid.. | |
| 06.04. | BIOFRONTERA : Announces Preliminary Product Revenues for the First Quarter of 2022 - Form .. | |
| 06.04. | Biofrontera Inc. Announces Preliminary Product Revenues for the First Quarter of 2022 | |
| 06.04. | Biofrontera Inc. Announces Preliminary Product Revenues for the First Quarter of 2022 | |
| 05.04. | BIOFRONTERA INC. : Entry into a Material Definitive Agreement, Change in Directors or Prin.. | |
| 04.04. | European ADRs Nudge Higher in Monday Trading | |
| 01.04. | Biofrontera Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on April.. | |
| 30.03. | European ADRs Move Higher in Wednesday Trading | |
| 17.03. | Biofrontera to Showcase Actinic Keratoses and Impetigo Treatments at the 2022 American .. | |
| 17.03. | European ADRs Nudge Higher in Thursday Trading | |
| 14.03. | Biofrontera Inc. Announces FDA Orange Book Listing of U.S. Patent for BF-RhodoLED® XL, .. | |
| 09.03. | Biofrontera Inc. to Present at the 34th Annual Roth Conference | |
| 08.03. | BIOFRONTERA INC. : Change in Directors or Principal Officers, Financial Statements and Exh.. | |
| 07.03. | Biofrontera Inc. Appoints Kevin D. Weber to its Board of Directors | |
| 07.03. | Biofrontera Inc. Appoints Kevin D. Weber to its Board of Directors | |
| 01.02. | Top Midday Gainers | |
| 01.02. | Biofrontera Completes 70% of Enrollment in Phase 3 of Skin Cancer Study; Shares Rise | |
| 01.02. | Biofrontera Inc. provides Update on Patient Recruitment for Phase III Study for the Tre.. | |
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
